These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10837726)

  • 1. Delivery of contrast agents for positron emission tomography imaging by liposomes.
    Oku N
    Adv Drug Deliv Rev; 1999 Apr; 37(1-3):53-61. PubMed ID: 10837726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography.
    Oku N; Tokudome Y; Tsukada H; Okada S
    Biochim Biophys Acta; 1995 Aug; 1238(1):86-90. PubMed ID: 7654755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo trafficking of long-circulating liposomes in tumour-bearing mice determined by positron emission tomography.
    Oku N; Tokudome Y; Tsukada H; Kosugi T; Namba Y; Okada S
    Biopharm Drug Dispos; 1996 Jul; 17(5):435-41. PubMed ID: 8830978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography.
    Oku N; Tokudome Y; Namba Y; Saito N; Endo M; Hasegawa Y; Kawai M; Tsukada H; Okada S
    Biochim Biophys Acta; 1996 Apr; 1280(1):149-54. PubMed ID: 8634309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine is enhanced by long-circulating liposomalization.
    Asai T; Kurohane K; Shuto S; Awano H; Matsuda A; Tsukada H; Namba Y; Okada S; Oku N
    Biol Pharm Bull; 1998 Jul; 21(7):766-71. PubMed ID: 9703265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcoma.
    Tokudome Y; Oku N; Doi K; Namba Y; Okada S
    Biochim Biophys Acta; 1996 Feb; 1279(1):70-4. PubMed ID: 8624364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer therapy using glucuronate modified long-circulating liposomes.
    Oku N
    Adv Drug Deliv Rev; 1999 Nov; 40(1-2):63-73. PubMed ID: 10837780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor accumulation of novel RES-avoiding liposomes.
    Oku N; Namba Y; Okada S
    Biochim Biophys Acta; 1992 Jun; 1126(3):255-60. PubMed ID: 1637853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time trafficking of PEGylated liposomes in the rodent focal brain ischemia analyzed by positron emission tomography.
    Fukuta T; Ishii T; Asai T; Nakamura G; Takeuchi Y; Sato A; Agato Y; Shimizu K; Akai S; Fukumoto D; Harada N; Tsukada H; Kawaguchi AT; Oku N
    Artif Organs; 2014 Aug; 38(8):662-6. PubMed ID: 25295359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of adriamycin encapsulated in long-circulating liposomes on Meth-A-sarcoma-bearing mice.
    Oku N; Doi K; Namba Y; Okada S
    Int J Cancer; 1994 Aug; 58(3):415-9. PubMed ID: 8050822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-1, 2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes.
    Mori A; Wu SP; Han I; Khokhar AR; Perez-Soler R; Huang L
    Cancer Chemother Pharmacol; 1996; 37(5):435-44. PubMed ID: 8599866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes.
    Litzinger DC; Buiting AM; van Rooijen N; Huang L
    Biochim Biophys Acta; 1994 Feb; 1190(1):99-107. PubMed ID: 8110825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
    Unezaki S; Maruyama K; Ishida O; Takahashi N; Iwatsuru M
    J Drug Target; 1993; 1(4):287-92. PubMed ID: 8069570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of brain cancer with positron emitter-labeled liposomes.
    Oku N; Yamashita M; Katayama Y; Urakami T; Hatanaka K; Shimizu K; Asai T; Tsukada H; Akai S; Kanazawa H
    Int J Pharm; 2011 Jan; 403(1-2):170-7. PubMed ID: 20934495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-circulating liposomes.
    Oku N; Namba Y
    Crit Rev Ther Drug Carrier Syst; 1994; 11(4):231-70. PubMed ID: 7664348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronate-modified liposomes with prolonged circulation time.
    Namba Y; Sakakibara T; Masada M; Ito F; Oku N
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1663-6. PubMed ID: 2208378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large liposomes containing ganglioside GM1 accumulate effectively in spleen.
    Liu D; Mori A; Huang L
    Biochim Biophys Acta; 1991 Jul; 1066(2):159-65. PubMed ID: 1854781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels.
    Ichikawa K; Hikita T; Maeda N; Yonezawa S; Takeuchi Y; Asai T; Namba Y; Oku N
    Biochim Biophys Acta; 2005 May; 1669(1):69-74. PubMed ID: 15843001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effect of reticuloendothelial system (RES)-avoiding liposomes containing a phospholipid analogue of 5-fluorouracil, dipalmitoylphosphatidylfluorouridine, in Meth A sarcoma-bearing mice.
    Doi K; Oku N; Toyota T; Shuto S; Sakai A; Itoh H; Okada S
    Biol Pharm Bull; 1994 Oct; 17(10):1414-6. PubMed ID: 7874068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.